Caas Capital Management LP Bio N Tech Se Transaction History
Caas Capital Management LP
- $552 Million
- Q4 2024
A detailed history of Caas Capital Management LP transactions in Bio N Tech Se stock. As of the latest transaction made, Caas Capital Management LP holds 17,190 shares of BNTX stock, worth $2.03 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
17,190
Previous 17,190
-0.0%
Holding current value
$2.03 Million
Previous $2.04 Million
4.07%
% of portfolio
0.35%
Previous 0.24%
Shares
8 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.5MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$982 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$534 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$515 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$224 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$214 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...